Intrinsic Value of S&P & Nasdaq Contact Us

Oncotelic Therapeutics, Inc. OTLC OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
22/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — OTLC

Oncotelic Therapeutics, Inc. (OTLC) has a market capitalization of $16.02M and trades at $0.04. The 52-week range is 0.02-0.11.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.6, Earnings Per Share (EPS) of $-0.01.

The stock has a beta of -0.59, operates in the Healthcare sector.

Trading Data
Current Price$0.04
52-Week Range0.02-0.11
Volume5.01K
Avg Volume (30D)298.04K
Market Cap$16.02M
Beta (1Y)-0.59
Company
IPO Date1993-08-26
Employees26
CEOVuong Trieu
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS6283411097
CUSIP628341109
Income (Latest Year)
EBITDA$-3.58B
Operating Income$-3.58B
Net Income$-4.52B
EPS$-0.01
EPS Diluted$-0.01
Shares Outstanding$404.4M
Balance Sheet (Latest Year)
Total Assets$26.68M
Current Assets$134.21K
Cash & ST Investments$86.13K
Total Liabilities$19.2M
Total Debt$13.09M
Net Debt$13M
Total Equity$7.48M
Debt / Equity1.75
Valuation Ratios
P/E Ratio-3.6
P/B Ratio2.14
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message